From additional regulatory requirements to transport refusal, the field of radiopharmaceutical trials can face additional red ...

The spacecraft—humanity's most distant probe—managed to resumed contact by switching to a secondary radio not used since 1981 ...

Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...

The FDA has received a biologics license application submission for RP1 plus nivolumab in patients with PD-1 ...